Skip to main content

Advertisement

Log in

The risk of ischemic stroke in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objective

Idiopathic inflammatory myopathies (IIM) are a group of chronic rheumatic diseases that can affect multiple systems; the risk of ischemic stroke in patients with IIM remains controversial. We aimed to systematically evaluate the risk of ischemic stroke in IIMs.

Methods

The PubMed, Embase, and Cochrane library were searched for relevant studies. Pooled relative risk (RR) with a 95% confidence interval (CI) was calculated as effect size to evaluate the risk of ischemic stroke in patients with IIM. Random effects model was chosen when I2 > 50%. We pooled all studies in a first total analysis to assess the risk of ischemic stroke in IIM. Subgroup analyses were conducted based on the subtypes of IIM (dermatomyositis) and country. Sensitivity analysis was performed to identify the heterogeneity sources.

Results

A total of 6 studies with 5,114 IIM cases and 14,516,099 controls were included, and the results demonstrated that IIMs were associated with an increased risk of ischemic stroke (RR = 2.41, 95% CI: 1.31, 4.45). Subgroup analysis indicated that patients with dermatomyositis (DM) had a 49% excess risk of ischemic stroke than controls; Asian patients with IIM had an increased risk of ischemic stroke, although not for American patients.

Conclusion

IIMs, especially patients with DM, are associated with an increased risk of ischemic stroke. Appropriate intervention may be taken into account for patients with IIM, especially when accompanied by other traditional risk factors of ischemic stroke.

Key Points

This study evaluated the risk of ischemic stroke in patients with IIMs.

Generally, IIMs are associated with an increased risk of ischemic stroke.

Patients with DM had a 49% excess risk of ischemic stroke than controls.

Subgroup analysis showed that Asian patients with IIMs were at increased risk of ischemic stroke, but not Americans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Code availability

Not applicable.

References

  1. Selva-O’Callaghan A, Pinal-Fernandez I, Trallero-Araguas E, Milisenda JC, Grau-Junyent JM, Mammen AL (2018) Classification and management of adult inflammatory myopathies. The Lancet Neurology 17:816–828. https://doi.org/10.1016/S1474-4422(18)30254-0

    Article  PubMed  Google Scholar 

  2. Mammen AL (2011) Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis. Nat Rev Neurol 7:343–354. https://doi.org/10.1038/nrneurol.2011.63

    Article  CAS  PubMed  Google Scholar 

  3. Marie I (2012) Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 14:275–285. https://doi.org/10.1007/s11926-012-0249-3

    Article  CAS  PubMed  Google Scholar 

  4. Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS et al (2019) Atherosclerosis Nat Rev Dis Primers 5:56. https://doi.org/10.1038/s41572-019-0106-z

    Article  PubMed  Google Scholar 

  5. Rai SK, Choi HK, Sayre EC, Avina-Zubieta JA (2016) Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study. Rheumatology (Oxford) 55:461–469. https://doi.org/10.1093/rheumatology/kev336

    Article  Google Scholar 

  6. Moshtaghi-Svensson J, Lundberg IE, Von Euler M, Arkema EV, Holmqvist M (2019) The risk of ischemic and hemorrhagic stroke in patients with idiopathic inflammatory myopathies: a Swedish population-based cohort study. Arthritis Care Res 71:970–976. https://doi.org/10.1002/acr.23702

    Article  Google Scholar 

  7. Keshishian A, Greenberg SA, Agashivala N, Baser O, Johnson K (2018) Health care costs and comorbidities for patients with inclusion body myositis. Curr Med Res Opin 34:1679–1685. https://doi.org/10.1080/03007995.2018.1486294

    Article  PubMed  Google Scholar 

  8. Chiang CH (2013) Dermatomyositis and risk of ischemic stroke: a nationwide study in Taiwan. Circulation 128:A16449

  9. Lai YT, Dai YS, Yen MF, Chen LS, Chen HH, Cooper RG et al (2013) Dermatomyositis is associated with an increased risk of cardiovascular and cerebrovascular events: a Taiwanese population-based longitudinal follow-up study. Br J Dermatol 168:1054–1059. https://doi.org/10.1111/bjd.12245

    Article  PubMed  Google Scholar 

  10. Silverberg JI, Kwa L, Kwa MC, Laumann AE, Ardalan K (2018) Cardiovascular and cerebrovascular comorbidities of juvenile dermatomyositis in US children: an analysis of the National Inpatient Sample. Rheumatology (Oxford) 57:694–702. https://doi.org/10.1093/rheumatology/kex465

    Article  Google Scholar 

  11. Olazagasti JM, Baez PJ, Wetter DA, Ernste FC (2015) Cancer risk in dermatomyositis: a meta-analysis of cohort studies. Am J Clin Dermatol 16:89–98. https://doi.org/10.1007/s40257-015-0120-1

    Article  PubMed  Google Scholar 

  12. Yang ZX, Lin F, Qin BD, Liang Y, Zhong RQ (2015) Polymyositis/dermatomyositis and malignancy risk: a meta analysis study. J Rheumatol 42:282–291. https://doi.org/10.3899/jrheum.140566

    Article  PubMed  Google Scholar 

  13. Chung WS, Lin CL, Sung FC, Lu CC, Kao CH (2014) Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study. Thromb Res 134:622–626. https://doi.org/10.1016/j.thromres.2014.06.021

    Article  CAS  PubMed  Google Scholar 

  14. Li YQ, Wang PH, Li L, Wang F, Liu YX (2018) Increased risk of venous thromboembolism associated with polymyositis and dermatomyositis: a meta-analysis. Ther Clin Risk Manag 14:157–165. https://doi.org/10.2147/TCRM.S157085

    Article  PubMed  PubMed Central  Google Scholar 

  15. Lee YH, Song GG (2017) Idiopathic inflammatory myopathy and the risk of venous thromboembolism: a meta-analysis. Rheumatol Int 37:1165–1173. https://doi.org/10.1007/s00296-017-3735-0

    Article  PubMed  Google Scholar 

  16. Carruthers EC, Choi HK, Sayre EC, Avina-Zubieta JA (2016) Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study. Ann Rheum Dis 75:110–116. https://doi.org/10.1136/annrheumdis-2014-205800

    Article  PubMed  Google Scholar 

  17. Lai CH, Hsieh CY, Barnado A, Huang LC, Chen SC, Tsai LM et al (2020) Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study. Rheumatology (Oxford) 59:1355–1363. https://doi.org/10.1093/rheumatology/kez456

    Article  Google Scholar 

  18. Barbhaiya M, Feldman CH, Guan H, Chen SK, Fischer MA, Solomon DH et al (2019) Racial/ethnic variation in stroke rates and risks among patients with systemic lupus erythematosus. Semin Arthritis Rheum 48:840–846. https://doi.org/10.1016/j.semarthrit.2018.07.012

    Article  PubMed  Google Scholar 

  19. Ballocca F, D’Ascenzo F, Moretti C, Omede P, Cerrato E, Barbero U et al (2015) Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis. Eur J Prev Cardiol 22:1435–1441. https://doi.org/10.1177/2047487314546826

    Article  PubMed  Google Scholar 

  20. Wiseman SJ, Ralston SH, Wardlaw JM (2016) Cerebrovascular disease in rheumatic diseases: a systematic review and meta-Analysis. Stroke 47:943–950. https://doi.org/10.1161/STROKEAHA.115.012052

    Article  PubMed  Google Scholar 

  21. Lundberg IE, Miller FW, Tjarnlund A, Bottai M (2016) Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med 280:39–51. https://doi.org/10.1111/joim.12524

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Feldman BM, Rider LG, Reed AM, Pachman LM (2008) Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 371:2201–2212. https://doi.org/10.1016/S0140-6736(08)60955-1

    Article  PubMed  Google Scholar 

  23. Lazarou IN, Guerne PA (2013) Classification, diagnosis, and management of idiopathic inflammatory myopathies. J Rheumatol 40:550–564. https://doi.org/10.3899/jrheum.120682

    Article  CAS  PubMed  Google Scholar 

  24. Ekholm L, Kahlenberg JM, Barbasso Helmers S, Tjarnlund A, Yalavarthi S, Zhao W et al (2016) Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis. Rheumatology (Oxford) 55:1987–1992. https://doi.org/10.1093/rheumatology/kew288

    Article  CAS  Google Scholar 

  25. Zanatta E, Colombo C, D’Amico G, d’Humieres T, Dal Lin C, Tona F (2019) Inflammation and coronary microvascular dysfunction in autoimmune rheumatic diseases. Int J Mol Sci 20:5563–5572. https://doi.org/10.3390/ijms20225563

    Article  CAS  PubMed Central  Google Scholar 

  26. Sallum AM, Kiss MH, Silva CA, Wakamatsu A, Vianna MA, Sachetti S et al (2006) Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis. Autoimmun Rev 5:93–100. https://doi.org/10.1016/j.autrev.2005.05.008

    Article  CAS  PubMed  Google Scholar 

  27. Esmon CT (2005) The interactions between inflammation and coagulation. Br J Haematol 131:417–430

    Article  CAS  Google Scholar 

  28. Regan M, Haque U, Pomper M, Pardo C, Stone J (2001) Central nervous system vasculitis as a complication of refractory dermatomyositis. J Rheumatol 28:207–211

    CAS  PubMed  Google Scholar 

  29. Ungprasert P, Cheungpasitporn W, Wijarnpreecha K, Ahuja W, Ratanasrimetha P, Thongprayoon C (2015) Risk of ischemic stroke in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis. Rheumatol Int 35:905–909. https://doi.org/10.1007/s00296-014-3166-0

    Article  CAS  PubMed  Google Scholar 

  30. Zoller B, Li X, Sundquist J, Sundquist K (2012) Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol 12:41. https://doi.org/10.1186/1471-2377-12-41

    Article  PubMed  PubMed Central  Google Scholar 

  31. Tisseverasinghe A, Bernatsky S, Pineau CA (2009) Arterial events in persons with dermatomyositis and polymyositis. J Rheumatol 36:1943–1946. https://doi.org/10.3899/jrheum.090061

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by grants from Qingdao Municipal Hospital, (No. VIII ZYZJJ-YJ201814).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xin Wang.

Ethics declarations

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Disclosures

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhen, C., Wang, Y., Wang, H. et al. The risk of ischemic stroke in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis. Clin Rheumatol 40, 4101–4108 (2021). https://doi.org/10.1007/s10067-021-05751-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-021-05751-2

Keywords

Navigation